Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction

Diltiazem (DZ) is widely prescribed in transplant recipients because of its drug-drug interactions with calcineurin inhibitors (CNI). However, these interactions have been primarily investigated in renal transplantation, and data regarding the long-term efficacy and safety of DZ in orthotopic heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyaydin, Emyal, Reinecke, Holger, Tuleta, Izabela, Sindermann, Juergen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575791/
https://www.ncbi.nlm.nih.gov/pubmed/36254022
http://dx.doi.org/10.1097/MD.0000000000031166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575791/
https://www.ncbi.nlm.nih.gov/pubmed/36254022
http://dx.doi.org/10.1097/MD.0000000000031166

Ejemplares similares